Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy

/PRNewswire/ -- Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy,...

Related Keywords

Norway ,Oslo ,United States ,Switzerland ,Norwegian ,Mortene Iversen ,Federico Grego ,Christer Kjos ,Lars Prestegarden ,Frazer Hall Mark ,Merck Co Inc ,University Of Bergen Norway ,Merck Sharp Dohme Corp ,Merck Sharp ,Dohme Corp ,Chief Business Officer ,Mark Swallow ,George Underwood ,Cytovation As ,